Related Experiment Video

Updated: Feb 23, 2026

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.0K

LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death

Ji-Hye Yoon1, Jung-Soon Mo2, Mi-Yeon Kim1

  • 1Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.

Biochimica Et Biophysica Acta. Molecular Cell Research
|September 11, 2017
PubMed

Insights

Leucine-rich repeat kinase 2 (LRRK2) directly phosphorylates and activates apoptosis signal-regulating kinase 1 (ASK1), contributing to neuronal cell death. This discovery reveals a key mechanism in Parkinson's disease pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) is a key genetic factor in Parkinson's disease (PD).
  • Understanding LRRK2's molecular targets and mechanisms is crucial for PD pathogenesis research.

Purpose of the Study:

  • To identify novel substrates of LRRK2.
  • To elucidate the role of LRRK2 in neuronal cell death pathways.
  • To investigate the direct interaction between LRRK2 and apoptosis signal-regulating kinase 1 (ASK1).

Main Methods:

  • In vitro kinase assays to determine LRRK2 phosphorylation of ASK1.
  • Binding assays to assess LRRK2 interactions with the ASK1-MKK3/6-p38 MAPK pathway.
  • Analysis of LRRK2-induced apoptosis in patient-derived neuronal stem cells.

Main Results:

  • LRRK2 directly phosphorylates and activates ASK1 at Thr832.
  • LRRK2 functions as a scaffolding protein, enhancing the ASK1-MKK3/6-p38 MAPK pathway.
  • Inhibition of ASK1 suppressed LRRK2-induced neuronal apoptosis in PD-derived stem cells.

Conclusions:

  • LRRK2 acts as an upstream kinase in the ASK1 pathway.
  • LRRK2 plays a significant role in PD pathogenesis through the ASK1 signaling cascade.
  • Targeting the LRRK2-ASK1 interaction may offer therapeutic strategies for Parkinson's disease.
Keywords:
ASK1LRRK2MAPKNeuronal cell deathPhosphorylation

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.5K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

16.2K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.7K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K